Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Wesseling

Showing results (51-60 of 53) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 53 results.
Gene Therapy|July 5, 2001
Improved gene transfer efficiency to primary and established human pancreatic carcinoma target cells via epidermal growth factor receptor and integrin-targeted adenoviral vectorsJ G Wesseling, P J Bosma, V Krasnykh, et al.
Arthritis Research & Therapy|September 16, 2016
Changes in peripheral blood lymphocyte subsets during arthritis development in arthralgia patientsJoyce Lübbers, Marian H van Beers-Tas, Saskia Vosslamber, et al.
Arthritis Research & Therapy|February 18, 2016
Physiological evidence for diversification of IFNα- and IFNβ-mediated response programs in different autoimmune diseasesTamarah D de Jong, Saskia Vosslamber, Elise Mantel, et al.
Pageof 6

Showing results (51-60 of 53) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 53 results.
Gene Therapy|July 5, 2001
Improved gene transfer efficiency to primary and established human pancreatic carcinoma target cells via epidermal growth factor receptor and integrin-targeted adenoviral vectorsJ G Wesseling, P J Bosma, V Krasnykh, et al.
Arthritis Research & Therapy|September 16, 2016
Changes in peripheral blood lymphocyte subsets during arthritis development in arthralgia patientsJoyce Lübbers, Marian H van Beers-Tas, Saskia Vosslamber, et al.
Arthritis Research & Therapy|February 18, 2016
Physiological evidence for diversification of IFNα- and IFNβ-mediated response programs in different autoimmune diseasesTamarah D de Jong, Saskia Vosslamber, Elise Mantel, et al.
Pageof 6